Multi-component nutritional supplement

Multi-component nutritional supplement has been studied in 2 papers since 2024: 2 trials in people; 1 in the past year. The newest paper, Jan 21, 2026: “Developing a multicomponent nturitional supplement to enhance cognitive function in older adults-- a precision biomarker analysis”.

InterventionHuman trials

2 papers study it8 findingsUpdated

More supplements

See all 2 papers on multi-component nutritional supplement

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country; 1 trial, none about aging.

“No significant effect of the supplement was observed for GDF-15, a marker linked to aging.”
A combination nutritional supplement reduces DNA methylation age only in older adults with a raised epigenetic ageGeroScience2024doi:10.1007/s11357-024-01138-8

2 of its findings point the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country
  • 2 findings against
  • 1 trial, none about aging
  • Funders: Bayer and 2 more
  • 8 of 8 findings with company ties
  • Human trial2

Studies in people

1 study gave multi-component nutritional supplement to people and measured what changed.

What changedDesignPeopleSource

down: Decreases InflammAge-4.055%

no change: Has no effect on Horvath clock

down: Decreases C-reactive protein-28.3%

Trial12 weeks83 people31 males, 52 females72.2 ± 6.4 yearsHealthy older adults aged ≥ 60 yearsGeroScience, Mar 26, 2024

What did studies of multi-component nutritional supplement find?

5

Studies of multi-component nutritional supplement measured 5 outcomes, among them C-reactive protein, epigenetic age and GDF-15.

C-reactive protein

no changein humans1downin humans1−28%

1 study
  1. Multi-component nutritional supplement showed no clear effect on C-reactive protein in all participants.

    “No differences were observed pre- and post-treatment in plasma GDF-15 and CRP”

    Human trialin all participantsplasma12-week

    A combination nutritional supplement reduces DNA methylation age only in older adults with a raised epigenetic age

    GeroScience

  2. Multi-component nutritional supplement decreases C-reactive protein in participants with hsCRP of 3 μg/ml or more at baseline (p = 0.0195).

    “participants with CRP indicative of an elevated cardiovascular disease risk (hsCRP ≥ 3μg/ml), had a reduction in CRP post-supplementation (p = 0.0195)”

    Human trialin participants with hsCRP of 3 μg/ml or more at baseline12-week

    A combination nutritional supplement reduces DNA methylation age only in older adults with a raised epigenetic age

    GeroScience

  3. Multi-component nutritional supplement decreases C-reactive protein in the higher CVD risk group (baseline CRP ≥ 3 μg/ml) (-28.3%).

    “revealed a significant 28.3% decline in CRP levels following treatment in the nine participants in the high-risk group compared with V1 (p < 0.0195; Table”

    Human trialin the higher CVD risk group (baseline CRP ≥ 3 μg/ml)12 weeksn = 9

    A combination nutritional supplement reduces DNA methylation age only in older adults with a raised epigenetic age

    GeroScience

More on C-reactive protein

Epigenetic age

no changein humans1downin humans1

1 study
  1. Multi-component nutritional supplement showed no clear effect on epigenetic age in all participants.

    “No difference between the epigenetic and chronological ages of participants was observed pre- and post-treatment by the blood-based Horvath or Hannum clocks”

    Human trialin all participantswhole blood12-week

    A combination nutritional supplement reduces DNA methylation age only in older adults with a raised epigenetic age

    GeroScience

  2. Multi-component nutritional supplement decreases epigenetic age in participants with epigenetic age acceleration of 2 years or more at baseline (p = 0.015; p = 0.0058).

    “a significant reduction in epigenetic age (p = 0.015) and epigenetic age acceleration (p = 0.0058) was observed post-treatment”

    Human trialin participants with epigenetic age acceleration of 2 years or more at baselinesaliva12-week

    A combination nutritional supplement reduces DNA methylation age only in older adults with a raised epigenetic age

    GeroScience

More on Epigenetic age

GDF-15

no changein humans1

1 study
  1. Multi-component nutritional supplement showed no clear effect on GDF-15 in humans.

    “No significant effect of the supplement was observed for GDF-15, a marker linked to aging.”

    Human trial12 weeksn = 83

    A combination nutritional supplement reduces DNA methylation age only in older adults with a raised epigenetic age

    GeroScience

More on GDF-15

Horvath clock

no changein humans1

1 study
  1. Multi-component nutritional supplement showed no clear effect on Horvath clock in humans.

    “Further analysis examining the difference in Hannum and Horvath epigenetic age acceleration of participants pre and post nutraceutical treatment revealed no significant change in participant epigenetic age acceleration following treatment, for either clock (Fig. C and D, respectively).”

    Human trial12 weeks

    A combination nutritional supplement reduces DNA methylation age only in older adults with a raised epigenetic age

    GeroScience

More on Horvath clock

InflammAge

downin humans1−4.1%

1 study
  1. Multi-component nutritional supplement decreases InflammAge in participants with baseline InflammAge ≥ 2 years higher than chronological age (-4.055%).

    “The supplement reduced the InflammAge score in this group by 4.055%, equivalent to 3.31 years, (p = 0.015; Fig. B) and the degree of InflammAge acceleration by 46.77%, equivalent to 3.47 years, (p = 0.0058; Fig. D).”

    Human trialin participants with baseline InflammAge ≥ 2 years higher than chronological age12 weeksn = 29

    A combination nutritional supplement reduces DNA methylation age only in older adults with a raised epigenetic age

    GeroScience

More on InflammAge

Has multi-component nutritional supplement been tested in people?

0 of 1 about aging

Yes: 2 trials in people have been published, and 1 trial is registered.

In trials

Trial sponsors

Latest

Dec 2025: 0Jan 2026: 1Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months